Oaktree Acquisition Corp. III Life Sciences OACC

OACC Company Overview

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (SPAC) formed to identify, evaluate, and complete a business combination within the healthcare and life sciences sectors. The company was sponsored by affiliates of Oaktree Capital Management, a global alternative investment manager, and was established as part of Oaktree’s broader strategy of leveraging sector-focused investment vehicles to pursue acquisition opportunities in industries with long-term growth potential. As a SPAC, OACC did not conduct traditional operating business activities prior to completing or pursuing a merger transaction; instead, its primary function was capital raising and acquisition execution.

The company focused on identifying targets across biotechnology, medical devices, diagnostics, healthcare services, and related life sciences technologies. Its positioning was based on access to Oaktree’s institutional investment platform, operational expertise, healthcare industry relationships, and capital markets experience. Public filings indicated that the company sought businesses with scalable platforms, differentiated intellectual property, or strong commercial growth profiles within healthcare innovation markets. Data regarding finalized operating activities or long-term standalone operations remains limited because SPAC entities are transitional corporate structures whose business model depends on consummating a merger transaction.